諾華製藥 NVS 深 滬
已收盤 12-24 16:00:00 美东时间
138.88
-0.250
-0.18%
華盛通- 最 高139.48
- 今 開139.06
- 成交量 64.69万股
- 最 低 138.53
- 昨 收 139.13
- 總市值 2665.11亿
- 52周最高 140.175
- 市盈率 靜 23.68
- 換手率 0.00%
- 52周最低 93.6329
- 委 比 39.39%
- 總股本 19.19亿
- 歷史最高 140.175
- 量 比 0.37
- 振 幅 0.68%
- 歷史最低 6.9614
- 每 手 1
- 風險率 11.26%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Novartis AG (NOVN) Receives a Buy from J.P. Morgan
In a report released yesterday, Richard Vosser from J.P. Morgan maintained a Bu...
12-24 11:15
默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持
多家美国及欧洲大型制药企业近日与白宫达成协议，同意自愿下调在美销售的药品价格，以换取关税豁免和政策支持
12-20 07:00
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts
Healthcare ETFs stay resilient as Big Pharma agrees to Medicaid drug price cuts. Here's what is cushioning ETFs despite pricing pressure.
12-20 04:17
Novartis' myasthenia gravis asset iptacopan granted FDA Orphan Drug status
The US FDA has granted Orphan Drug designation to Novartis' (NVS) iptacopan for myasthenia gravis. The drug, an oral, selective Factor B inhibitor, is already approved under the name Fabhalta for par...
12-20 03:57
Why Is Athira Pharma Stock Spiking After Breast Cancer Asset Acquisition?
Athira Pharma stock jumps on heavy volume after securing lasofoxifene Phase 3 rights and $90 million financing, extending cash runway into 2028.
12-19 03:17
Stock Of The Day: Has The Uber Meltdown Begun?
Shares of Uber Technologies (UBER) have broken a support level. This means a new downtrend may be forming.
12-19 02:25
What's Going On With Western Digital Stock Thursday?
Western Digital (NASDAQ:WDC) shares are rising in sympathy with Micron, which beat first-quarter estimates and issued strong guidance.
12-19 00:10
White House Readies Drug Price Deals With AbbVie, Novartis, Roche
AbbVie and other drugmakers may announce U.S. drug pricing deals on Friday as the White House pushes lower prices and Medicare payment reforms.
12-18 23:14
Lunai Bioworks (NASDAQ: LNAI) Featured in International Business Times as AI Partnership Talks Advance
AI-powered drug discovery and biodefense company engages pharma on CNS programs amid rising deal activity SACRAMENTO, Calif., Dec. 18, 2025 /PRNewswire/ -- Lunai Bioworks Inc. (NASDAQ: LNAI)...
12-18 22:00
